首页/数据集/Multivariate analysis of pretransplant available (clinical) parameters predicting tumor response to IBT (n = 59).

Multivariate analysis of pretransplant available (clinical) parameters predicting tumor response to IBT (n = 59).

Figshare2015-12-02 更新2026-04-29 收录

肿瘤治疗响应

临床参数多变量分析

数据链接：

https://figshare.com/articles/dataset/_Multivariate_analysis_of_pretransplant_available_clinical_parameters_predicting_tumor_response_to_IBT_n_8202_8202_59_/174904 数据链接链接失效反馈

官方服务：

资源简介：

CI: confidence interval.PET: positron emission tomography.OR: odds ratio.

应用场景：

创建时间：

2015-12-02

癌症预后预测

肿瘤治疗响应

Background: Cellular senescence is a novel hallmark of cancer associated with patient outcomes and tumor immunotherapy. However, the value of cellular senescence-related long non-coding RNAs (lncRNAs)

NIAID Data Ecosystem20

Table S7 from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy

肿瘤治疗响应

基因表达谱分析

Supplemental Table S7. Hallmark gene sets up in ACT-treated relapse (R) HCmel3 melanomas versus early during treatment (EDT) HCmel3 melanomas (GSEA results).

NIAID Data Ecosystem10

RNA Sequencing of Intratumoral Immune Populations in Pancreatic Ductal Adenocarcinoma Following Radiotherapy and Interleukin 12 Treatment. RNA Sequencing of Intratumoral Immune Populations in Pancreatic Ductal Adenocarcinoma Following Radiotherapy and Interleukin 12 Treatment

胰腺癌免疫微环境

肿瘤治疗响应

We report differential gene expression in inflammatory monocyte (IM), tumor-associated macrophage (TAM), and CD8 T cell populations following stereotactic body radiation (SBRT), intratumoral interleuk

NIAID Data Ecosystem10

Antigen-presenting cell/T/NK cell-related genes risk model for prognosis and immune therapeutic efficacy in patients with glioma

胶质瘤预后预测

肿瘤治疗响应

Antigen-Presenting Cell/T/Natural Killer (APC/T/NK) cells are important in anti-tumour invasion, and the suppression of their functions leads to resistance of glioma patients to chemotherapy. The purp

Mendeley Data20

Table1_Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma.docx

胶质瘤预后预测

肿瘤治疗响应

Background: Glioma is one of the most aggressive cancer types affecting the central nerve system, with poor overall survival (OS) rates. The present study aimed to construct a novel immune-related sig

NIAID Data Ecosystem10

Multivariate analysis of pretransplant available (clinical) parameters predicting tumor response to IBT (n = 59).

资源简介：

相关数据集